Robert E Reiter

Title(s)Professor, Urology
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Multifunctional immunoPET tracers for pancreatic and prostate cancer
    NIH R01CA174294Apr 1, 2013 - Jul 31, 2021
    Role: Co-Principal Investigator
    UCLA SPORE in Prostate Cancer
    NIH P50CA092131Jul 1, 2001 - Aug 31, 2024
    Role: Principal Investigator
    MARKERS OF ANDROGEN INDEPENDENT PROSTATE CANCER
    NIH K08CA074169Jul 29, 1997 - Jun 30, 2002
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. Eur Urol. 2022 Apr 22. Kishan AU, Wang X, Sun Y, Romero T, Michalski JM, Ma TM, Feng FY, Sandler HM, Bolla M, Maingon P, De Reijke T, Neven A, Steigler A, Denham JW, Joseph D, Nabid A, Carrier N, Souhami L, Sydes MR, Dearnaley DP, Syndikus I, Tree AC, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Efstathiou JA, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Xiang M, Rettig MB, Reiter RE, Zaorsky NG, Ong WL, Dess RT, Steinberg ML, Nickols NG, Roy S, Garcia JA, Spratt DE, MARCAP Consortium. PMID: 35469702.
      View in: PubMed   Mentions:
    2. Impact of a Novel Molecular Imaging Modality, Prostate-Specific Membrane Antigen Positron Emission Tomography, on the Management of Prostate Cancer. J Clin Oncol. 2022 Feb 24; JCO2102940. Patel NA, Reiter RE. PMID: 35201894.
      View in: PubMed   Mentions:
    3. Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT. Prostate Cancer Prostatic Dis. 2022 Jan 20. Kane N, Romero T, Diaz-Perez S, Rettig MB, Steinberg ML, Kishan AU, Schaue D, Reiter RE, Knudsen BS, Nickols NG. PMID: 35058580.
      View in: PubMed   Mentions:
    4. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis. Lancet Oncol. 2022 02; 23(2):304-316. Kishan AU, Sun Y, Hartman H, Pisansky TM, Bolla M, Neven A, Steigler A, Denham JW, Feng FY, Zapatero A, Armstrong JG, Nabid A, Carrier N, Souhami L, Dunne MT, Efstathiou JA, Sandler HM, Guerrero A, Joseph D, Maingon P, de Reijke TM, Maldonado X, Ma TM, Romero T, Wang X, Rettig MB, Reiter RE, Zaorsky NG, Steinberg ML, Nickols NG, Jia AY, Garcia JA, Spratt DE, MARCAP Consortium group. PMID: 35051385.
      View in: PubMed   Mentions:
    5. The utility of prostate MRI within active surveillance: description of the evidence. World J Urol. 2022 Jan; 40(1):71-77. Dominique G, Brisbane WG, Reiter RE. PMID: 34860274; PMCID: PMC8813688.
      View in: PubMed   Mentions:
    6. Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer. J Urol. 2022 04; 207(4):823-831. Kinnaird A, Yerram NK, O'Connor L, Brisbane W, Sharma V, Chuang R, Jayadevan R, Ahdoot M, Daneshvar M, Priester A, Delfin M, Tran E, Barsa DE, Sisk A, Reiter RE, Felker E, Raman S, Kwan L, Choyke PL, Merino MJ, Wood BJ, Turkbey B, Pinto PA, Marks LS, Kinnaird A, Yerram NK, O'Connor L, Brisbane W, Sharma V, Chuang R, Jayadevan R, Ahdoot M, Daneshvar M, Priester A, Delfin M, Tran E, Barsa DE, Sisk A, Reiter RE, Felker E, Raman S, Kwan L, Choyke PL, Merino MJ, Wood BJ, Turkbey B, Pinto PA, Marks LS. PMID: 34854746.
      View in: PubMed   Mentions:
    7. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. JAMA Netw Open. 2021 12 01; 4(12):e2138550. Xiang M, Ma TM, Savjani R, Pollom EL, Karnes RJ, Grogan T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Huland H, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Alam R, Schwen Z, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Chong N, Kupelian PA, Rettig MB, Zaorsky NG, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Tilki D, Czernin J, Gafita A, Romero T, Calais J, Kishan AU. PMID: 34902034; PMCID: PMC8669522.
      View in: PubMed   Mentions:
    8. Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial. JAMA Oncol. 2021 11 01; 7(11):1635-1642. Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, Reiter RE, Holden S, Herrmann K, Zhu S, Fendler WP, Czernin J, Calais J. PMID: 34529005; PMCID: PMC8446902.
      View in: PubMed   Mentions: 1     Fields:    
    9. Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer. JAMA Oncol. 2021 11 01; 7(11):1644-1652. Aggarwal R, Rydzewski NR, Zhang L, Foye A, Kim W, Helzer KT, Bakhtiar H, Chang SL, Perry MD, Gleave M, Reiter RE, Huang J, Evans CP, Alumkal JJ, Lang JM, Yu M, Quigley DA, Sjöström M, Small EJ, Feng FY, Zhao SG. PMID: 34554200; PMCID: PMC8461554.
      View in: PubMed   Mentions:    Fields:    
    10. Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI with histopathology gold-standard in the detection, intra-prostatic localization and local extension of primary prostate cancer: results from a prospective single-center imaging trial. J Nucl Med. 2021 Oct 14. Sonni I, Felker ER, Lenis AT, Sisk AE, Bahri S, Allen-Auerbach MS, Armstrong WR, Suvannarerg V, Tubtawee T, Grogan T, Elashoff D, Eiber M, Raman SS, Czernin J, Reiter R, Calais J. PMID: 34649942.
      View in: PubMed   Mentions:    Fields:    
    11. Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI. Prostate. 2021 Dec; 81(16):1450. Cipollari S, Jamshidi N, Du L, Sung K, Huang D, Margolis DJ, Huang J, Reiter RE, Kuo MD. PMID: 34591333.
      View in: PubMed   Mentions:    Fields:    
    12. Textured-Based Deep Learning in Prostate Cancer Classification with 3T Multiparametric MRI: Comparison with PI-RADS-Based Classification. Diagnostics (Basel). 2021 Sep 28; 11(10). Liu Y, Zheng H, Liang Z, Miao Q, Brisbane WG, Marks LS, Raman SS, Reiter RE, Yang G, Sung K. PMID: 34679484; PMCID: PMC8535024.
      View in: PubMed   Mentions:
    13. Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials. Prostate Cancer Prostatic Dis. 2021 Aug 16. Jiang T, Markovic D, Patel J, Juarez JE, Ma TM, Shabsovich D, Nickols NG, Reiter RE, Elashoff D, Rettig MB, Zaorsky NG, Spratt DE, Kishan AU. PMID: 34400799.
      View in: PubMed   Mentions: 1     Fields:    
    14. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. JAMA Netw Open. 2021 07 01; 4(7):e2115312. Kishan AU, Karnes RJ, Romero T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Huland H, Tran PT, Martin S, Martínez-Monge R, Krauss DJ, Abu-Isa EI, Alam R, Schwen Z, Chang AJ, Pisansky TM, Choo R, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Chong N, Kupelian PA, D'Amico AV, Rettig MB, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Tilki D. PMID: 34196715; PMCID: PMC8251338.
      View in: PubMed   Mentions:    Fields:    
    15. Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. Eur Urol. 2021 08; 80(2):142-146. Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Valle L, Chong N, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Tilki D, Karnes RJ, Klein EA, Tosoian JJ, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Kupelian PA, Rettig MB, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Kishan AU. PMID: 33985797.
      View in: PubMed   Mentions: 1     Fields:    
    16. Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer. J Urol. 2021 09; 206(3):595-603. Raman AG, Sarma KV, Raman SS, Priester AM, Mirak SA, Riskin-Jones HH, Dhinagar N, Speier W, Felker E, Sisk AE, Lu D, Kinnaird A, Reiter RE, Marks LS, Arnold CW. PMID: 33908801; PMCID: PMC8903239.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Tissue clearing techniques for three-dimensional optical imaging of intact human prostate and correlations with multi-parametric MRI. Prostate. 2021 06; 81(9):521-529. Cipollari S, Jamshidi N, Du L, Sung K, Huang D, Margolis DJ, Huang J, Reiter RE, Kuo MD. PMID: 33876838.
      View in: PubMed   Mentions:    Fields:    
    18. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol Ther. 2021 07 07; 29(7):2335-2349. Murad JP, Tilakawardane D, Park AK, Lopez LS, Young CA, Gibson J, Yamaguchi Y, Lee HJ, Kennewick KT, Gittins BJ, Chang WC, Tran CP, Martinez C, Wu AM, Reiter RE, Dorff TB, Forman SJ, Priceman SJ. PMID: 33647456; PMCID: PMC8261088.
      View in: PubMed   Mentions:
    19. Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging. Eur Urol Oncol. 2022 Feb; 5(1):100-103. Ma TM, Gafita A, Shabsovich D, Juarez J, Grogan TR, Thin P, Armstrong W, Sonni I, Nguyen K, Lok V, Reiter RE, Rettig MB, Steinberg ML, Kupelian PA, Yang DD, Muralidhar V, Chu C, Feng F, Savjani R, Deng J, Parikh NR, Nickols NG, Elashoff D, Czernin J, Calais J, Kishan AU. PMID: 33602654.
      View in: PubMed   Mentions: 3     Fields:    
    20. Prostate cancer. Nat Rev Dis Primers. 2021 02 04; 7(1):9. Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, Gillessen S, Van der Kwast T, Bristow RG. PMID: 33542230.
      View in: PubMed   Mentions:
    21. The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer. Eur Urol Focus. 2021 03; 7(2):258-266. Murthy V, Sonni I, Jariwala N, Juarez R, Reiter RE, Raman SS, Hope TA. PMID: 33541838.
      View in: PubMed   Mentions: 1     Fields:    
    22. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. J Natl Compr Canc Netw. 2021 02 02; 19(2):134-143. Schaeffer E, Srinivas S, Antonarakis ES, Armstrong AJ, Bekelman JE, Cheng H, D'Amico AV, Davis BJ, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Horwitz EM, Ippolito JE, Kuettel MR, Lang JM, McKay R, McKenney J, Netto G, Penson DF, Pow-Sang JM, Reiter R, Richey S, Roach Iii M, Rosenfeld S, Shabsigh A, Spratt DE, Teply BA, Tward J, Shead DA, Freedman-Cass DA. PMID: 33545689.
      View in: PubMed   Mentions: 12     Fields:    
    23. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. 2021 09; 80(3):280-292. Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, Reiter RE, Rettig M, Calais J, Nickols NG, Dess RT, Spratt DE, Steinberg ML, Nguyen PL, Davis BJ, Zaorsky NG, Kishan AU. PMID: 33309278.
      View in: PubMed   Mentions: 10     Fields:    
    24. High-dose per Fraction Radiotherapy Induces Both Antitumor Immunity and Immunosuppressive Responses in Prostate Tumors. Clin Cancer Res. 2021 03 01; 27(5):1505-1515. Lin L, Kane N, Kobayashi N, Kono EA, Yamashiro JM, Nickols NG, Reiter RE. PMID: 33219015.
      View in: PubMed   Mentions: 4     Fields:    
    25. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings. J Urol. 2021 02; 205(2):444-451. Pooli A, Johnson DC, Shirk J, Markovic D, Sadun TY, Sisk AE, Mohammadian Bajgiran A, Afshari Mirak S, Felker ER, Hughes AK, Raman SS, Reiter RE. PMID: 33026934.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer. Mol Imaging Biol. 2020 10; 22(5):1380-1391. Tsai WK, Zettlitz KA, Dahlbom M, Reiter RE, Wu AM. PMID: 32661830; PMCID: PMC7688013.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    27. Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV. Can J Urol. 2020 10; 27(5):10352-10362. Crawford ED, Andriole G, Freedland SJ, Garnick M, Gomella LG, Henderson J, Higano CT, Kader AK, Kane C, Keane TE, Koo PJ, Petrylak DP, Reiter RE, Slovin SF, Yu EY. PMID: 33049187.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Autoantibody Landscape in Patients with Advanced Prostate Cancer. Clin Cancer Res. 2020 12 01; 26(23):6204-6214. Chen WS, Haynes WA, Waitz R, Kamath K, Vega-Crespo A, Shrestha R, Zhang M, Foye A, Baselga Carretero I, Perez Garcilazo I, Zhang M, Zhao SG, Sjöström M, Quigley DA, Chou J, Beer TM, Rettig M, Gleave M, Evans CP, Lara P, Chi KN, Reiter RE, Alumkal JJ, Ashworth A, Aggarwal R, Small EJ, Daugherty PS, Ribas A, Oh DY, Shon JC, Feng FY. PMID: 32967941; PMCID: PMC7710628.
      View in: PubMed   Mentions: 2     Fields:    
    29. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study. Eur Urol Oncol. 2020 Sep 18. Lenis AT, Pooli A, Lec PM, Sadun TY, Johnson DC, Lebacle C, Fendler WP, Eiber M, Czernin J, Reiter RE, Calais J. PMID: 32958451.
      View in: PubMed   Mentions:    Fields:    
    30. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. Eur J Nucl Med Mol Imaging. 2021 02; 48(2):501-508. Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, PSMA PET Reader Group, Slavik R, Carroll PR, Lawhn-Heath C, Herrmann K, Czernin J, Hope TA. PMID: 32808077; PMCID: PMC7835157.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2020 09 01; 26(17):4616-4624. Guan X, Sun D, Lu E, Urrutia JA, Reiter RE, Rettig M, Evans CP, Lara P, Gleave M, Beer TM, Thomas GV, Huang J, Aggarwal RR, Quigley DA, Foye A, Chen WS, Youngren J, Weinstein AS, Stuart JM, Feng FY, Small EJ, Xia Z, Alumkal JJ. PMID: 32727885; PMCID: PMC7484240.
      View in: PubMed   Mentions: 2     Fields:    
    32. The DNA methylation landscape of advanced prostate cancer. Nat Genet. 2020 08; 52(8):778-789. Zhao SG, Chen WS, Li H, Foye A, Zhang M, Sjöström M, Aggarwal R, Playdle D, Liao A, Alumkal JJ, Das R, Chou J, Hua JT, Barnard TJ, Bailey AM, Chow ED, Perry MD, Dang HX, Yang R, Moussavi-Baygi R, Zhang L, Alshalalfa M, Laura Chang S, Houlahan KE, Shiah YJ, Beer TM, Thomas G, Chi KN, Gleave M, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Yvonne Kim M, Fong L, Spratt DE, Morgan TM, Bose R, Huang FW, Li H, Chesner L, Shenoy T, Goodarzi H, Asangani IA, Sandhu S, Lang JM, Mahajan NP, Lara PN, Evans CP, Febbo P, Batzoglou S, Knudsen KE, He HH, Huang J, Zwart W, Costello JF, Luo J, Tomlins SA, Wyatt AW, Dehm SM, Ashworth A, Gilbert LA, Boutros PC, Farh K, Chinnaiyan AM, Maher CA, Small EJ, Quigley DA, Feng FY. PMID: 32661416; PMCID: PMC7454228.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    33. The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells. Prostate Cancer Prostatic Dis. 2021 03; 24(1):135-139. Nickols NG, Ganapathy E, Nguyen C, Kane N, Lin L, Diaz-Perez S, Nazarian R, Mathis C, Felix C, Basehart V, Zomorodian N, Kwak J, Kishan AU, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Chu FI, Romero T, Elashoff D, Reiter RE, Schaue D. PMID: 32647353; PMCID: PMC7794088.
      View in: PubMed   Mentions: 2     Fields:    
    34. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2. Abdom Radiol (NY). 2020 07; 45(7):2225-2234. Afshari Mirak S, Mohammadian Bajgiran A, Sung K, Asvadi NH, Markovic D, Felker ER, Lu D, Sisk A, Reiter RE, Raman SS. PMID: 31549211.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020 11 15; 108(4):930-935. Parikh NR, Kishan AU, Kane N, Diaz-Perez S, Ganapathy E, Nazarian R, Felix C, Mathis C, Bradley M, Sachdeva A, Wyatt B, Basehart V, Zomorodian N, Lin L, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Elashoff D, Schaue D, Reiter RE, Nickols NG. PMID: 32562839; PMCID: PMC8261839.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    36. Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020 11 15; 108(4):917-926. Parikh NR, Chang EM, Nickols NG, Rettig MB, Raldow AC, Steinberg ML, Koontz BF, Vapiwala N, Deville C, Feng FY, Spratt DE, Reiter RE, Phillips R, Ost P, Tran PT, Kishan AU. PMID: 32544574.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology. Radiology. 2020 08; 296(2):348-355. Zhang Z, Wu HH, Priester A, Magyar C, Afshari Mirak S, Shakeri S, Mohammadian Bajgiran A, Hosseiny M, Azadikhah A, Sung K, Reiter RE, Sisk AE, Raman S, Enzmann DR. PMID: 32515678.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. The Role of Opioids and Their Receptors in Urological Malignancy: A Review. J Urol. 2020 Dec; 204(6):1150-1159. Lec PM, Lenis AT, Golla V, Brisbane W, Shuch B, Garraway IP, Reiter RE, Chamie K. PMID: 32516030.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer. Eur Urol. 2020 09; 78(3):327-332. Kishan AU, Romero T, Alshalalfa M, Liu Y, Tran PT, Nickols NG, Ye H, Sajed D, Rettig MB, Reiter RE, Garraway IP, Spratt DE, Freedland SJ, Zhao X, Li Z, Deek M, Livingstone J, Mahal BA, Nguyen PL, Feng FY, Den RB, Schaeffer EM, Lotan TL, Karnes RJ, Klein EA, Ross AE, Grogan T, Davicioni E, Elashoff D, Boutros PC, Weidhaas JB. PMID: 32461072; PMCID: PMC8954568.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    40. Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance. Proc Natl Acad Sci U S A. 2020 06 02; 117(22):12315-12323. Alumkal JJ, Sun D, Lu E, Beer TM, Thomas GV, Latour E, Aggarwal R, Cetnar J, Ryan CJ, Tabatabaei S, Bailey S, Turina CB, Quigley DA, Guan X, Foye A, Youngren JF, Urrutia J, Huang J, Weinstein AS, Friedl V, Rettig M, Reiter RE, Spratt DE, Gleave M, Evans CP, Stuart JM, Chen Y, Feng FY, Small EJ, Witte ON, Xia Z. PMID: 32424106; PMCID: PMC7275746.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    41. Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. J Nucl Med. 2020 12; 61(12):1793-1799. Fendler WP, Ferdinandus J, Czernin J, Eiber M, Flavell RR, Behr SC, Wu IK, Lawhn-Heath C, Pampaloni MH, Reiter RE, Rettig MB, Gartmann J, Murthy V, Slavik R, Carroll PR, Herrmann K, Calais J, Hope TA. PMID: 32358094.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    42. [89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model. Mol Imaging Biol. 2020 04; 22(2):367-376. Zettlitz KA, Tsai WK, Knowles SM, Salazar FB, Kobayashi N, Reiter RE, Wu AM. PMID: 31209779; PMCID: PMC6920577.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    43. Caught Between a Rock and a Hard Place. Int J Radiat Oncol Biol Phys. 2021 03 15; 109(4):846-847. Kishan AU, Reiter RE. PMID: 32173187.
      View in: PubMed   Mentions:    Fields:    
    44. Influence of the Location and Zone of Tumor in Prostate Cancer Detection and Localization on 3-T Multiparametric MRI Based on PI-RADS Version 2. AJR Am J Roentgenol. 2020 05; 214(5):1101-1111. Wibulpolprasert P, Raman SS, Hsu W, Margolis DJA, Asvadi NH, Khoshnoodi P, Moshksar A, Tan N, Ahuja P, Maehara CK, Sisk A, Sayre J, Lu DSK, Reiter RE. PMID: 32130048.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 2020 04; 77(4):508-547. Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A. PMID: 32001144.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    46. Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study. J Nucl Med. 2020 08; 61(8):1153-1160. Sonni I, Eiber M, Fendler WP, Alano RM, Vangala SS, Kishan AU, Nickols N, Rettig MB, Reiter RE, Czernin J, Calais J. PMID: 31924715; PMCID: PMC7413232.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    47. Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer. Prostate Cancer Prostatic Dis. 2020 06; 23(2):316-323. Chen WS, Feng EL, Aggarwal R, Foye A, Beer TM, Alumkal JJ, Gleave M, Chi KN, Reiter RE, Rettig MB, Evans CP, Small EJ, Sharifi N, Zhao SG. PMID: 31745256; PMCID: PMC7529063.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    48. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. Eur Urol. 2020 02; 77(2):201-208. Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, Wang X, Pugh SE, Sandler KA, Bolla M, Maingon P, De Reijke T, Nickols NG, Rettig M, Drakaki A, Liu ST, Reiter RE, Chang AJ, Feng FY, Sajed D, Nguyen PL, Kupelian PA, Steinberg ML, Boutros PC, Elashoff D, Collette L, Sandler HM. PMID: 31718822; PMCID: PMC7008470.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    49. Efficacy of a preprostatectomy multi-modal penile rehabilitation regimen on recovery of postoperative erectile function. Int J Impot Res. 2020 May; 32(3):323-328. Osadchiy V, Eleswarapu SV, Mills SA, Pollard ME, Reiter RE, Mills JN. PMID: 31474755.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    50. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 2019 09; 20(9):1286-1294. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. PMID: 31375469; PMCID: PMC7469487.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    51. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI. AJR Am J Roentgenol. 2019 09; 213(3):W134-W142. Bajgiran AM, Mirak SA, Sung K, Sisk AE, Reiter RE, Raman SS. PMID: 31216201.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Focal Therapy Should Not Be Considered for Men with Gleason Grade Group 3-5 Prostate Cancer. Eur Urol Focus. 2020 03 15; 6(2):203-204. Johnson DC, Reiter RE. PMID: 31202786.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 01; 5(6):856-863. Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA. PMID: 30920593; PMCID: PMC6567829.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCTClinical Trials
    54. The Evolving Role of Prostate-Specific Membrane Antigen-Based Diagnostics and Therapeutics in Prostate Cancer. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:321-330. Dorff TB, Fanti S, Farolfi A, Reiter RE, Sadun TY, Sartor O. PMID: 31099673.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    55. Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CT. Clin Nucl Med. 2019 05; 44(5):e353-e356. Lubin DJ, Holden SB, Rettig MB, Reiter RE, King CR, Lee JM, Wallace DW, Calais J. PMID: 30789399.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection. Cancer. 2019 09 01; 125(17):2955-2964. Johnson DC, Yang JJ, Kwan L, Barsa DE, Mirak SA, Pooli A, Sadun T, Jayadevan R, Zhou S, Priester AM, Natarajan S, Bajgiran AM, Shakeri S, Sisk A, Felker ER, Raman SS, Marks LS, Reiter RE. PMID: 31042322; PMCID: PMC7368458.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    57. Detection and Localization of Prostate Cancer at 3-T Multiparametric MRI Using PI-RADS Segmentation. AJR Am J Roentgenol. 2019 Apr 17; W1-W10. Wibulpolprasert P, Raman SS, Hsu W, Margolis DJA, Asvadi NH, Khoshnoodi P, Moshksar A, Tan N, Ahuja P, Maehara CK, Huang J, Sayre J, Lu DSK, Reiter RE. PMID: 30995090.
      View in: PubMed   Mentions: 1     Fields:    
    58. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. Eur Urol. 2020 01; 77(1):3-10. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. PMID: 30992160; PMCID: PMC7521828.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    59. Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease. BMC Cancer. 2019 Apr 01; 19(1):291. Parikh NR, Huiza C, Patel JS, Tsai S, Kalpage N, Thein M, Pitcher S, Lee SP, Inouye WS, Jordan ML, Sanati H, Jafari L, Bennett CJ, Gin GE, Kishan AU, Reiter RE, Lewis M, Sadeghi A, Aronson WJ, Garraway IP, Rettig MB, Nickols NG. PMID: 30935383; PMCID: PMC6444674.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    60. A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III). J Urol. 2019 04; 201(4):682-692. Crawford ED, Koo PJ, Shore N, Slovin SF, Concepcion RS, Freedland SJ, Gomella LG, Karsh L, Keane TE, Maroni P, Penson D, Petrylak DP, Ross A, Mouraviev V, Reiter RE, Divgi C, Yu EY, RADAR III Group. PMID: 30077557.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    61. Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2019 11; 76(5):562-571. Chen WS, Aggarwal R, Zhang L, Zhao SG, Thomas GV, Beer TM, Quigley DA, Foye A, Playdle D, Huang J, Lloyd P, Lu E, Sun D, Guan X, Rettig M, Gleave M, Evans CP, Youngren J, True L, Lara P, Kothari V, Xia Z, Chi KN, Reiter RE, Maher CA, Feng FY, Small EJ, Alumkal JJ, West Coast Prostate Cancer Dream Team. PMID: 30928160; PMCID: PMC6764911.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    62. Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity. Mol Cancer Res. 2019 06; 17(6):1235-1240. Aggarwal RR, Quigley DA, Huang J, Zhang L, Beer TM, Rettig MB, Reiter RE, Gleave ME, Thomas GV, Foye A, Playdle D, Lloyd P, Chi KN, Evans CP, Lara PN, Feng FY, Alumkal JJ, Small EJ. PMID: 30918106; PMCID: PMC6548614.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    63. Three Tesla Multiparametric Magnetic Resonance Imaging: Comparison of Performance with and without Endorectal Coil for Prostate Cancer Detection, PI-RADS™ version 2 Category and Staging with Whole Mount Histopathology Correlation. J Urol. 2019 03; 201(3):496-502. Mirak SA, Shakeri S, Bajgiran AM, Felker ER, Sung KH, Asvadi NH, Khoshnoodi P, Markovic D, Ponzini D, Ahuja P, Sisk A, Reiter RE, Lu D, Raman SS. PMID: 30273608.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    64. MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer. Prostate Cancer Prostatic Dis. 2019 12; 22(4):531-538. Nickols NG, Nazarian R, Zhao SG, Tan V, Uzunangelov V, Xia Z, Baertsch R, Neeman E, Gao AC, Thomas GV, Howard L, De Hoedt AM, Stuart J, Goldstein T, Chi K, Gleave ME, Graff JN, Beer TM, Drake JM, Evans CP, Aggarwal R, Foye A, Feng FY, Small EJ, Aronson WJ, Freedland SJ, Witte ON, Huang J, Alumkal JJ, Reiter RE, Rettig MB. PMID: 30804427; PMCID: PMC6853839.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    65. Cancer core length from targeted biopsy: an index of prostate cancer volume and pathological stage. BJU Int. 2019 08; 124(2):275-281. Simopoulos DN, Sisk AE, Priester A, Felker ER, Kwan L, Delfin MK, Reiter RE, Marks LS. PMID: 30694605; PMCID: PMC6641990.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    66. Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. Eur Urol Oncol. 2021 04; 4(2):327-330. Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU. PMID: 31411981.
      View in: PubMed   Mentions:    Fields:    
    67. Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer. Eur Urol. 2019 07; 76(1):18-23. Houlahan KE, Salmasi A, Sadun TY, Pooli A, Felker ER, Livingstone J, Huang V, Raman SS, Ahuja P, Sisk AE, Boutros PC, Reiter RE. PMID: 30685078.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    68. Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis. JAMA Oncol. 2019 01 01; 5(1):91-96. Kishan AU, Wang X, Seiferheld W, Collette L, Sandler KA, Sandler HM, Bolla M, Maingon P, De Reijke T, Hanks GE, Nickols NG, Rettig M, Drakaki A, Reiter RE, Spratt DE, Kupelian PA, Steinberg ML, King CR. PMID: 30326032; PMCID: PMC6440243.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    69. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy. J Urol. 2019 01; 201(1):91-97. Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE. PMID: 30577397.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    70. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy. J Urol. 2019 01; 201(1):91-97. Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE. PMID: 30142318.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    71. Adjusting Our Approach to Multiparametric Magnetic Resonance Imaging-based Targeted Prostate Biopsies: Considerations After the FUTURE Trial. Eur Urol. 2019 04; 75(4):591-592. Sadun TY, Reiter RE. PMID: 30591355.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging. Eur Urol. 2019 05; 75(5):712-720. Johnson DC, Raman SS, Mirak SA, Kwan L, Bajgiran AM, Hsu W, Maehara CK, Ahuja P, Faiena I, Pooli A, Salmasi A, Sisk A, Felker ER, Lu DSK, Reiter RE. PMID: 30509763.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    73. Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody. Theranostics. 2018; 8(21):5903-5914. Tsai WK, Zettlitz KA, Tavaré R, Kobayashi N, Reiter RE, Wu AM. PMID: 30613270; PMCID: PMC6299441.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    74. 3T multiparametric MR imaging, PIRADSv2-based detection of index prostate cancer lesions in the transition zone and the peripheral zone using whole mount histopathology as reference standard. Abdom Radiol (NY). 2018 11; 43(11):3117-3124. Asvadi NH, Afshari Mirak S, Mohammadian Bajgiran A, Khoshnoodi P, Wibulpolprasert P, Margolis D, Sisk A, Reiter RE, Raman SS. PMID: 29725743; PMCID: PMC6922085.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer. EJNMMI Res. 2018 Oct 29; 8(1):96. Lückerath K, Wei L, Fendler WP, Evans-Axelsson S, Stuparu AD, Slavik R, Mona CE, Calais J, Rettig M, Reiter RE, Herrmann K, Radu CG, Czernin J, Eiber M. PMID: 30374743; PMCID: PMC6206308.
      View in: PubMed   Mentions: 22  
    76. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models. Clin Cancer Res. 2019 01 01; 25(1):188-200. Zhang M, Kobayashi N, Zettlitz KA, Kono EA, Yamashiro JM, Tsai WK, Jiang ZK, Tran CP, Wang C, Guan J, Wu AM, Reiter RE. PMID: 30301826; PMCID: PMC6559730.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    77. Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68Ga-PSMA-11 PET/CT. Clin Genitourin Cancer. 2019 02; 17(1):e53-e55. Polverari G, Ceci F, Allen-Auerbach M, Gupta P, Fishbein MC, Reiter RE, Lee JM, Hope TA, Carroll RM, Czernin J, Calais J. PMID: 30293922.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    78. Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate. Abdom Radiol (NY). 2018 09; 43(9):2487-2496. Nagarajan MB, Raman SS, Lo P, Lin WC, Khoshnoodi P, Sayre JW, Ramakrishna B, Ahuja P, Huang J, Margolis DJA, Lu DSK, Reiter RE, Goldin JG, Brown MS, Enzmann DR. PMID: 29460041; PMCID: PMC6946380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer Pathology. Eur Urol Oncol. 2018 10; 1(5):378-385. Kang JJ, Reiter RE, Steinberg ML, King CR. PMID: 31158076.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    80. A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research. J Magn Reson Imaging. 2019 01; 49(1):270-279. Wu HH, Priester A, Khoshnoodi P, Zhang Z, Shakeri S, Afshari Mirak S, Asvadi NH, Ahuja P, Sung K, Natarajan S, Sisk A, Reiter R, Raman S, Enzmann D. PMID: 30069968.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    81. Radical prostatectomy then and now: Surgical overtreatment of prostate cancer is declining from 2009 to 2016 at a tertiary referral center. Urol Oncol. 2018 09; 36(9):401.e19-401.e25. Salmasi A, Faiena I, Wu J, Sisk AE, Sachveda A, Vandel JJ, Chamie K, Marks LS, Reiter RE. PMID: 30064933.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 2018 07 26; 174(3):758-769.e9. Quigley DA, Dang HX, Zhao SG, Lloyd P, Aggarwal R, Alumkal JJ, Foye A, Kothari V, Perry MD, Bailey AM, Playdle D, Barnard TJ, Zhang L, Zhang J, Youngren JF, Cieslik MP, Parolia A, Beer TM, Thomas G, Chi KN, Gleave M, Lack NA, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Ryan CJ, Fong L, Kim W, Friedlander T, Chou J, Li H, Das R, Li H, Moussavi-Baygi R, Goodarzi H, Gilbert LA, Lara PN, Evans CP, Goldstein TC, Stuart JM, Tomlins SA, Spratt DE, Cheetham RK, Cheng DT, Farh K, Gehring JS, Hakenberg J, Liao A, Febbo PG, Shon J, Sickler B, Batzoglou S, Knudsen KE, He HH, Huang J, Wyatt AW, Dehm SM, Ashworth A, Chinnaiyan AM, Maher CA, Small EJ, Feng FY. PMID: 30033370; PMCID: PMC6425931.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansCells
    83. Registration Accuracy of Patient-Specific, Three-Dimensional-Printed Prostate Molds for Correlating Pathology With Magnetic Resonance Imaging. IEEE Trans Biomed Eng. 2019 01; 66(1):14-22. Priester A, Wu H, Khoshnoodi P, Schneider D, Zhang Z, Asvadi NH, Sisk A, Raman S, Reiter R, Grundfest W, Marks LS, Natarajan S. PMID: 29993431; PMCID: PMC6344233.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    84. Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer. J Nucl Med. 2018 11; 59(11):1714-1721. Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, Ceci F, Reiter RE, Rettig MB, Hegde JV, Shaverdian N, King CR, Steinberg ML, Czernin J, Nickols NG. PMID: 29653978; PMCID: PMC6225538.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    85. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):883-888. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. PMID: 29976500.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. Detection Threshold and Reproducibility of 68Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer. J Nucl Med. 2018 09; 59(9):1392-1397. Lückerath K, Stuparu AD, Wei L, Kim W, Radu CG, Mona CE, Calais J, Rettig M, Reiter RE, Czernin J, Slavik R, Herrmann K, Eiber M, Fendler WP. PMID: 29602819; PMCID: PMC6910618.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    87. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody. J Nucl Med. 2018 09; 59(9):1398-1405. Zettlitz KA, Tsai WK, Knowles SM, Kobayashi N, Donahue TR, Reiter RE, Wu AM. PMID: 29602820; PMCID: PMC6126441.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    88. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy. J Urol. 2018 09; 200(3):564-572. Salmasi A, Said J, Shindel AW, Khoshnoodi P, Felker ER, Sisk AE, Grogan T, McCullough D, Bennett J, Bailey H, Lawrence HJ, Elashoff DA, Marks LS, Raman SS, Febbo PG, Reiter RE. PMID: 29524506.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    89. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. JAMA. 2018 03 06; 319(9):896-905. Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. PMID: 29509865; PMCID: PMC5885899.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    90. Anatomic and Molecular Imaging in Prostate Cancer. Cold Spring Harb Perspect Med. 2018 03 01; 8(3). Miller ET, Salmasi A, Reiter RE. PMID: 28710256; PMCID: PMC5830905.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    91. Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy. Am J Clin Oncol. 2018 Jan; 41(1):1-5. Kang JJ, Reiter RE, Kummer N, DeKernion J, Steinberg ML, King CR. PMID: 26237192; PMCID: PMC6946377.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    92. Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence. J Nucl Med. 2018 03; 59(3):434-441. Calais J, Fendler WP, Eiber M, Gartmann J, Chu FI, Nickols NG, Reiter RE, Rettig MB, Marks LS, Ahlering TE, Huynh LM, Slavik R, Gupta P, Quon A, Allen-Auerbach MS, Czernin J, Herrmann K. PMID: 29242398; PMCID: PMC5868499.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    93. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer. J Natl Cancer Inst. 2017 Dec 01; 109(12). Wyatt AW, Annala M, Aggarwal R, Beja K, Feng F, Youngren J, Foye A, Lloyd P, Nykter M, Beer TM, Alumkal JJ, Thomas GV, Reiter RE, Rettig MB, Evans CP, Gao AC, Chi KN, Small EJ, Gleave ME. PMID: 29206995; PMCID: PMC6440274.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCells
    94. Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT. J Nucl Med. 2018 03; 59(3):469-478. Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, Hope T, Reiter R, Maurer T, Weber WA, Fendler WP. PMID: 29123012.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    95. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology. J Urol. 2018 05; 199(5):1218-1223. Tan N, Shen L, Khoshnoodi P, Alcalá HE, Yu W, Hsu W, Reiter RE, Lu DY, Raman SS. PMID: 29128577; PMCID: PMC6946378.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    96. Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility Study. JCO Clin Cancer Inform. 2017 11; 1:1-6. Kishan AU, Cheng EM, Schmidt E, Saigal C, Reiter RE, Kupelian PA, Steinberg ML, King CR. PMID: 30657383.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer. Oncoimmunology. 2018; 7(2):e1380764. Priceman SJ, Gerdts EA, Tilakawardane D, Kennewick KT, Murad JP, Park AK, Jeang B, Yamaguchi Y, Yang X, Urak R, Weng L, Chang WC, Wright S, Pal S, Reiter RE, Wu AM, Brown CE, Forman SJ. PMID: 29308300; PMCID: PMC5749625.
      View in: PubMed   Mentions: 34  
    98. Why Targeting PSMA Is a Game Changer in the Management of Prostate Cancer. J Nucl Med. 2018 02; 59(2):177-182. Donin NM, Reiter RE. PMID: 28986509; PMCID: PMC6910619.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    99. Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy. J Urol. 2018 02; 199(2):453-458. Nassiri N, Chang E, Lieu P, Priester AM, Margolis DJA, Huang J, Reiter RE, Dorey FJ, Marks LS, Natarajan S. PMID: 28830754; PMCID: PMC5780241.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    100. Multi-parametric magnetic resonance imaging as a management decision tool. Transl Androl Urol. 2017 Jun; 6(3):472-482. Johnson DC, Reiter RE. PMID: 28725589; PMCID: PMC5503956.
      View in: PubMed   Mentions: 6  
    101. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer. Urology. 2017 Sep; 107:171-177. Hegde JV, Veruttipong D, Said JW, Reiter RE, Steinberg ML, King CR, Kishan AU. PMID: 28552819; PMCID: PMC6986738.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    102. Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma. Radiology. 2017 07; 284(1):109-119. Jamshidi N, Margolis DJ, Raman S, Huang J, Reiter RE, Kuo MD. PMID: 28453432; PMCID: PMC6197054.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    103. Imaging and Pathology Correlations for Different Risk Stratification Models for Intermediate-risk Prostate Cancer. Anticancer Res. 2017 03; 37(3):1237-1242. Ellis-Caleo T, Hegde JV, Batth S, Mesko S, Reiter R, Margolis D, Kamrava M. PMID: 28314287.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    104. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2016 10 18; 113(42):E6457-E6466. Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter RE, Pitteri SJ, Huang J, Witte ON. PMID: 27694579; PMCID: PMC5081658.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    105. Risk stratification of prostate cancer 2016. Scand J Clin Lab Invest Suppl. 2016; 245:S54-9. Reiter RE. PMID: 27533326.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    106. First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. J Nucl Med. 2016 Dec; 57(12):1858-1864. Pandit-Taskar N, O'Donoghue JA, Ruan S, Lyashchenko SK, Carrasquillo JA, Heller G, Martinez DF, Cheal SM, Lewis JS, Fleisher M, Keppler JS, Reiter RE, Wu AM, Weber WA, Scher HI, Larson SM, Morris MJ. PMID: 27516450; PMCID: PMC5450345.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    107. Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology. J Urol. 2017 02; 197(2):320-326. Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, Huang J, Grundfest W, Marks LS. PMID: 27484386; PMCID: PMC5540646.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    108. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol. 2017 05; 71(5):766-773. Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. PMID: 27452951.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    109. Is Targeted Biopsy Applicable to Patients on Active Surveillance? Eur Urol. 2017 02; 71(2):181-182. Prado K, Reiter RE. PMID: 27292867.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    110. Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States. J Urol. 2016 Oct; 196(4):1096-104. Taneja SS, Bennett J, Coleman J, Grubb R, Andriole G, Reiter RE, Marks L, Azzouzi AR, Emberton M. PMID: 27291652; PMCID: PMC5483996.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    111. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies. Cancer. 2016 Mar 15; 122(6):884-92. Filson CP, Natarajan S, Margolis DJ, Huang J, Lieu P, Dorey FJ, Reiter RE, Marks LS. PMID: 26749141; PMCID: PMC4777653.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    112. Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time. Clin Cancer Res. 2016 Mar 15; 22(6):1403-12. Sonn GA, Behesnilian AS, Jiang ZK, Zettlitz KA, Lepin EJ, Bentolila LA, Knowles SM, Lawrence D, Wu AM, Reiter RE. PMID: 26490315; PMCID: PMC4794340.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    113. Accelerated echo planar J-resolved spectroscopic imaging in prostate cancer: a pilot validation of non-linear reconstruction using total variation and maximum entropy. NMR Biomed. 2015 Nov; 28(11):1366-73. Nagarajan R, Iqbal Z, Burns B, Wilson NE, Sarma MK, Margolis DA, Reiter RE, Raman SS, Thomas MA. PMID: 26346702; PMCID: PMC4618758.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    114. Prostate diffusion imaging with distortion correction. Magn Reson Imaging. 2015 Nov; 33(9):1178-1181. Rakow-Penner RA, White NS, Margolis DJA, Parsons JK, Schenker-Ahmed N, Kuperman JM, Bartsch H, Choi HW, Bradley WG, Shabaik A, Huang J, Liss MA, Marks L, Kane CJ, Reiter RE, Raman SS, Karow DS, Dale AM. PMID: 26220859; PMCID: PMC4594204.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    115. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology. AJR Am J Roentgenol. 2015 Jul; 205(1):W87-92. Tan N, Margolis DJ, Lu DY, King KG, Huang J, Reiter RE, Raman SS. PMID: 26102423; PMCID: PMC4898906.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    116. A fully human scFv phage display library for rapid antibody fragment reformatting. Protein Eng Des Sel. 2015 Oct; 28(10):307-16. Li K, Zettlitz KA, Lipianskaya J, Zhou Y, Marks JD, Mallick P, Reiter RE, Wu AM. PMID: 25991864; PMCID: PMC4607741.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    117. Risk stratification of prostate cancer in the modern era. Curr Opin Urol. 2015 May; 25(3):246-51. Behesnilian AS, Reiter RE. PMID: 25730325; PMCID: PMC4454478.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    118. MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens. Front Oncol. 2015; 5:30. Liss MA, White NS, Parsons JK, Schenker-Ahmed NM, Rakow-Penner R, Kuperman JM, Bartsch H, Choi HW, Mattrey RF, Bradley WG, Shabaik A, Huang J, Margolis DJ, Raman SS, Marks LS, Kane CJ, Reiter RE, Dale AM, Karow DS. PMID: 25741473; PMCID: PMC4330697.
      View in: PubMed   Mentions: 5  
    119. Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy. J Urol. 2015 May; 193(5):1532-8. Kang JJ, Reiter RE, Steinberg ML, King CR. PMID: 25463990; PMCID: PMC4527538.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    120. Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer. Clin Cancer Res. 2014 Dec 15; 20(24):6367-78. Knowles SM, Tavaré R, Zettlitz KA, Rochefort MM, Salazar FB, Jiang ZK, Reiter RE, Wu AM. PMID: 25326233; PMCID: PMC4268335.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    121. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol. 2015 Mar; 67(3):569-76. Le JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS, Huang J, Margolis DJ, Raman SS, Reiter RE. PMID: 25257029.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    122. Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging. Cancer Res. 2014 Sep 01; 74(17):4638-52. White NS, McDonald C, McDonald CR, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Kaine CJ, Carter BS, Bradley WG, Dale AM. PMID: 25183788; PMCID: PMC4155409.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    123. Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer. Urol Oncol. 2014 Oct; 32(7):952-7. Sonn GA, Filson CP, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. PMID: 25027689; PMCID: PMC4254112.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    124. Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology. J Urol. 2014 Nov; 192(5):1367-73. Le JD, Stephenson S, Brugger M, Lu DY, Lieu P, Sonn GA, Natarajan S, Dorey FJ, Huang J, Margolis DJ, Reiter RE, Marks LS. PMID: 24793118; PMCID: PMC4201866.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    125. Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody. J Nucl Med. 2014 Mar; 55(3):452-9. Knowles SM, Zettlitz KA, Tavaré R, Rochefort MM, Salazar FB, Stout DB, Yazaki PJ, Reiter RE, Wu AM. PMID: 24504052; PMCID: PMC4052832.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    126. The role of magnetic resonance imaging in delineating clinically significant prostate cancer. Urology. 2014 Feb; 83(2):369-75. Chamie K, Sonn GA, Finley DS, Tan N, Margolis DJ, Raman SS, Natarajan S, Huang J, Reiter RE. PMID: 24468511; PMCID: PMC3922632.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    127. Multidimensional MR spectroscopic imaging of prostate cancer in vivo. NMR Biomed. 2014 Jan; 27(1):53-66. Thomas MA, Nagarajan R, Huda A, Margolis D, Sarma MK, Sheng K, Reiter RE, Raman SS. PMID: 23904127.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    128. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines. Prostate. 2013 Sep; 73(13):1378-90. Seiler D, Zheng J, Liu G, Wang S, Yamashiro J, Reiter RE, Huang J, Zeng G. PMID: 23728788.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    129. MR Spectroscopic Imaging of Peripheral Zone in Prostate Cancer Using a 3T MRI Scanner: Endorectal versus External Phased Array Coils. Magn Reson Insights. 2013; 6:51-8. Nagarajan R, Margolis DJ, Raman SS, Ouellette D, Sarma MK, Reiter RE, Thomas MA. PMID: 25114544; PMCID: PMC4089813.
      View in: PubMed   Mentions: 1  
    130. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol. 2014 Apr; 65(4):809-15. Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. PMID: 23523537; PMCID: PMC3858524.
      View in: PubMed   Mentions: 132     Fields:    Translation:Humans
    131. Radical prostatectomy: value of prostate MRI in surgical planning. Abdom Imaging. 2012 Aug; 37(4):664-74. Tan N, Margolis DJ, McClure TD, Thomas A, Finley DS, Reiter RE, Huang J, Raman SS. PMID: 21993567.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    132. Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers. Urology. 2012 Jul; 80(1):219-23. Finley DS, Ellingson BM, Natarajan S, Zaw TM, Raman SS, Schulam P, Reiter RE, Margolis D. PMID: 22748877.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    133. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores. J Magn Reson Imaging. 2012 Sep; 36(3):697-703. Nagarajan R, Margolis D, Raman S, Sarma MK, Sheng K, King CR, Verma G, Sayre J, Reiter RE, Thomas MA. PMID: 22581787.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    134. Use of MR imaging to determine preservation of the neurovascular bundles at robotic-assisted laparoscopic prostatectomy. Radiology. 2012 Mar; 262(3):874-83. McClure TD, Margolis DJ, Reiter RE, Sayre JW, Thomas MA, Nagarajan R, Gulati M, Raman SS. PMID: 22274837.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    135. Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer. Adv Urol. 2012; 2012:374805. Nagarajan R, Margolis D, Raman S, Sheng K, King C, Reiter R, Thomas MA. PMID: 22216026; PMCID: PMC3246296.
      View in: PubMed   Mentions: 28  
    136. Fine-tuning robot-assisted radical prostatectomy planning with MRI. Urol Oncol. 2013 Aug; 31(6):766-75. Finley DS, Margolis D, Raman SS, Ellingson BM, Natarajan S, Tan N, Huang J, Reiter RE. PMID: 21906964.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    137. Purification and direct transformation of epithelial progenitor cells from primary human prostate. Nat Protoc. 2011 May; 6(5):656-67. Goldstein AS, Drake JM, Burnes DL, Finley DS, Zhang H, Reiter RE, Huang J, Witte ON. PMID: 21527922; PMCID: PMC3092477.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    138. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med. 2010 Dec; 16(12):1414-20. Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, An J, Horvath S, Gleave M, Rettig MB, Wainberg ZA, Reiter RE. PMID: 21057494; PMCID: PMC3088104.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansAnimalsCells
    139. An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors. Eur J Nucl Med Mol Imaging. 2010 Aug; 37(8):1529-38. Lepin EJ, Leyton JV, Zhou Y, Olafsen T, Salazar FB, McCabe KE, Hahm S, Marks JD, Reiter RE, Wu AM. PMID: 20354850; PMCID: PMC2903645.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    140. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate. 2010 Apr 01; 70(5):491-501. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON. PMID: 19938015; PMCID: PMC2885946.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    141. Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways. Urol Oncol. 2011 Jan-Feb; 29(1):4-11. Wallerand H, Bernhard JC, Culine S, Ballanger P, Robert G, Reiter RE, Ferrière JM, Ravaud A. PMID: 19914099.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    142. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst. 2009 Jun 16; 101(12):888-92. Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. PMID: 19509365.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansPHPublic Health
    143. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res. 2009 Apr 15; 69(8):3332-8. Li Y, Wang L, Zhang M, Melamed J, Liu X, Reiter R, Wei J, Peng Y, Zou X, Pellicer A, Garabedian MJ, Ferrari A, Lee P. PMID: 19351848; PMCID: PMC3182465.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    144. The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers. Urol Oncol. 2010 Sep-Oct; 28(5):473-9. Wallerand H, Robert G, Pasticier G, Ravaud A, Ballanger P, Reiter RE, Ferrière JM. PMID: 19272800.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    145. The urologist role in basic and clinical translational research: Personal reflections of a urologic scientist. Urol Oncol. 2009 Mar-Apr; 27(2):127-8. Reiter RE. PMID: 19285226.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    146. Humanized radioiodinated minibody for imaging of prostate stem cell antigen-expressing tumors. Clin Cancer Res. 2008 Nov 15; 14(22):7488-96. Leyton JV, Olafsen T, Lepin EJ, Hahm S, Bauer KB, Reiter RE, Wu AM. PMID: 19010866; PMCID: PMC2720761.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    147. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors. Protein Eng Des Sel. 2009 Mar; 22(3):209-16. Leyton JV, Olafsen T, Sherman MA, Bauer KB, Aghajanian P, Reiter RE, Wu AM. PMID: 18957406; PMCID: PMC2644405.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    148. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol. 2009 May-Jun; 27(3):268-76. Fondrevelle ME, Kantelip B, Reiter RE, Chopin DK, Thiery JP, Monnien F, Bittard H, Wallerand H. PMID: 18440840.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    149. The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup study. J Urol. 2008 Apr; 179(4):1362-7; discussion 1367. van de Poll-Franse LV, Kwan L, Reiter RE, Lee SP, Litwin MS. PMID: 18289562.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    150. Androgen receptor and invasion in prostate cancer. Cancer Res. 2008 Feb 15; 68(4):1128-35. Hara T, Miyazaki H, Lee A, Tran CP, Reiter RE. PMID: 18281488.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    151. Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation. Prostate. 2008 Feb 01; 68(2):139-51. Moore ML, Teitell MA, Kim Y, Watabe T, Reiter RE, Witte ON, Dubey P. PMID: 18044730.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    152. What factors affect the PSA relapse-free survival times in patients treated with permanent seed brachytherapy? Nat Clin Pract Urol. 2007 Dec; 4(12):650-1. Reiter RE, Riggs S. PMID: 17955047.
      View in: PubMed   Mentions:    Fields:    
    153. A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther. 2007 Nov; 15(11):1973-81. Pariente N, Morizono K, Virk MS, Petrigliano FA, Reiter RE, Lieberman JR, Chen IS. PMID: 17653099.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    154. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007 Jun 01; 109(11):2239-47. Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Withers HR, Reiter RE. PMID: 17455209.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    155. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody. J Immunother. 2007 May-Jun; 30(4):396-405. Olafsen T, Gu Z, Sherman MA, Leyton JV, Witkosky ME, Shively JE, Raubitschek AA, Morrison SL, Wu AM, Reiter RE. PMID: 17457214.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    156. Improvements in prostate brachytherapy dosimetry due to seed stranding. Brachytherapy. 2007 Jan-Mar; 6(1):44-8. Lin K, Lee SP, Cho JS, Reiter RE, DeMarco JJ, Solberg TD. PMID: 17284385.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    157. An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer. Appl Immunohistochem Mol Morphol. 2006 Dec; 14(4):375-83. Rao DS, Gui D, Koski ME, Popoviciu LM, Wang H, Reiter RE, Said JW. PMID: 17122632.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    158. Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinase. Biochem Pharmacol. 2006 Nov 15; 72(10):1257-67. Zemskova M, Wechter W, Bashkirova S, Chen CS, Reiter R, Lilly MB. PMID: 16949054.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    159. Stem cells in prostate and prostate cancer development. Urol Oncol. 2006 Mar-Apr; 24(2):131-40. Lam JS, Reiter RE. PMID: 16520277.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    160. What are the operating characteristics of PSA screening for prostate cancer? Nat Clin Pract Urol. 2006 Feb; 3(2):74-5. Reiter RE, Shurtleff B. PMID: 16470202.
      View in: PubMed   Mentions:    Fields:    
    161. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism. Cancer Res. 2005 Oct 15; 65(20):9495-500. Gu Z, Yamashiro J, Kono E, Reiter RE. PMID: 16230414.
      View in: PubMed   Mentions: 39     Fields:    Translation:Animals
    162. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer. Pancreas. 2005 Aug; 31(2):119-25. Wente MN, Jain A, Kono E, Berberat PO, Giese T, Reber HA, Friess H, Büchler MW, Reiter RE, Hines OJ. PMID: 16024997.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    163. Prostate stem cell antigen is overexpressed in prostate cancer metastases. Clin Cancer Res. 2005 Apr 01; 11(7):2591-6. Lam JS, Yamashiro J, Shintaku IP, Vessella RL, Jenkins RB, Horvath S, Said JW, Reiter RE. PMID: 15814638.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    164. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res. 2005 Mar 15; 11(6):2237-43. Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, Brooks JD, Loda M, Reiter RE. PMID: 15788672.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    165. Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer. Clin Cancer Res. 2004 Dec 15; 10(24):8351-6. Thomas GV, Horvath S, Smith BL, Crosby K, Lebel LA, Schrage M, Said J, De Kernion J, Reiter RE, Sawyers CL. PMID: 15623612.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    166. Molecular markers and prostate cancer prognosis. Clin Prostate Cancer. 2004 Dec; 3(3):157-64. Chin JL, Reiter RE. PMID: 15636682.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    167. Trefoil factor 3 is overexpressed in human prostate cancer. Prostate. 2004 Nov 01; 61(3):209-14. Garraway IP, Seligson D, Said J, Horvath S, Reiter RE. PMID: 15368472.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    168. Genetic alterations in prostate cancer. Curr Urol Rep. 2004 Jun; 5(3):157-65. Chin JL, Reiter RE. PMID: 15161563.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    169. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. J Urol. 2004 Mar; 171(3):1117-21. Han KR, Seligson DB, Liu X, Horvath S, Shintaku PI, Thomas GV, Said JW, Reiter RE. PMID: 14767283.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    170. Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression. Urology. 2003 Jun; 61(6):1187-92. Freedland SJ, de Gregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Elashoff DA, Reiter RE, Aronson WJ. PMID: 12809895.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    171. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens. J Urol. 2003 Jun; 169(6):2094-100. Cheng L, Reiter RE, Jin Y, Sharon H, Wieder J, Lane TF, Rao J. PMID: 12771726.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    172. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. Prostate. 2003 Apr 01; 55(1):9-19. Christiansen JJ, Rajasekaran SA, Moy P, Butch A, Goodglick L, Gu Z, Reiter RE, Bander NH, Rajasekaran AK. PMID: 12640656.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    173. Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy. J Urol. 2003 Apr; 169(4):1325-30. Freedland SJ, deGregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Dorey F, Reiter RE, Aronson WJ. PMID: 12629353.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    174. Monoclonal antibody therapy for genitourinary oncology: promise for the future. J Urol. 2002 Dec; 168(6):2615-23. Palapattu GS, Reiter RE. PMID: 12441996.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    175. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res. 2002 Dec; 1(2):113-21. Tran CP, Lin C, Yamashiro J, Reiter RE. PMID: 12496358.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    176. Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol Endocrinol. 2002 Oct; 16(10):2323-37. Jain A, Lam A, Vivanco I, Carey MF, Reiter RE. PMID: 12351697.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    177. Role of prostate stem cell antigen in prostate cancer research. Curr Opin Urol. 2002 Sep; 12(5):401-6. Jalkut MW, Reiter RE. PMID: 12172427.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    178. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol. 2002 Jun 14; 3(7):RESEARCH0032. DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD. PMID: 12184806; PMCID: PMC126237.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    179. Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):401-6. Watabe T, Lin M, Ide H, Donjacour AA, Cunha GR, Witte ON, Reiter RE. PMID: 11752398; PMCID: PMC117572.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    Robert's Networks
    Concepts (503)
    Derived automatically from this person's publications.
    _
    Co-Authors (124)
    People in Profiles who have published with this person.
    _
    Similar People (59)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _